Cargando…

Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers

BACKGROUND: Patients with HIV mono-infection may develop chronic liver disease due to a number of factors including hepatic steatosis. We estimated the prevalence and predictors of hepatic steatosis and fibrosis in a cohort of HIV-mono-infected patients with persistently deranged liver function test...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lombardi, Rosa, Lever, Robert, Smith, Colette, Marshall, Neal, Rodger, Alison, Bhagani, Sanjay, Tsochatzis, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411386/ https://www.ncbi.nlm.nih.gov/pubmed/28469366 http://dx.doi.org/10.20524/aog.2017.0141

Ejemplares similares

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study
por: Logan, Sarah, et al.
Publicado: (2016)

Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics
por: Chrostek, Lech, et al.
Publicado: (2019)

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B
por: Poynard, Thierry, et al.
Publicado: (2011)

Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C
por: Tsochatzis, Emmanuel A, et al.
Publicado: (2014)

Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population
por: Dalbeni, Andrea, et al.
Publicado: (2023)

A simple noninvasive model to predict significant fibrosis in children with chronic hepatitis B
por: Zhang, Kang-Ling, et al.
Publicado: (2021)

Non-invasive assessment of liver fibrosis
por: Papastergiou, Vasilios, et al.
Publicado: (2012)

Serum Micro-RNA-122 Level as a Simple Noninvasive Marker of MAFLD Severity
por: Hegazy, Mona A, et al.
Publicado: (2021)

Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients
por: Yuan, Xiaoling, et al.
Publicado: (2019)

Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal
por: Seddon, Jo, et al.
Publicado: (2011)

Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B
por: Zeng, Xianghua, et al.
Publicado: (2015)

Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
por: Rockstroh, Jürgen K, et al.
Publicado: (2013)

Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals
por: Sulyok, Mihály, et al.
Publicado: (2017)

Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study
por: Warren-Gash, Charlotte, et al.
Publicado: (2017)

Diastolic wall strain: a simple marker of abnormal cardiac mechanics
por: Selvaraj, Senthil, et al.
Publicado: (2014)

Serum Hyaluronic Acid as a Noninvasive Marker of Hepatic Fibrosis in Chronic Hepatitis B
por: Geramizadeh, Bita, et al.
Publicado: (2008)

FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B
por: Zeremski, Marija, et al.
Publicado: (2014)

Noninvasive Fibrosis Marker Can Predict Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
por: Chung, Hyun Ah, et al.
Publicado: (2016)

Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma
por: Maegawa, Felipe B., et al.
Publicado: (2019)

Higher risk of renal impairment associated with tenofovir use amongst people living with HIV in India: A comparative cohort analysis between Western India and United Kingdom
por: Pujari, Sanjay N, et al.
Publicado: (2014)

Assessment of Liver Fibrosis: Noninvasive Means
por: Poynard, Thierry, et al.
Publicado: (2008)

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy
por: Pérez-Is, Laura, et al.
Publicado: (2022)

Sexual behaviour, recreational drug use and hepatitis C co-infection in HIV-diagnosed men who have sex with men in the United Kingdom: results from the ASTRA study
por: Daskalopoulou, Marina, et al.
Publicado: (2014)

Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Concordance between noninvasive assessments of fibrosis in patients with HIV/HIV+HBV infection
por: Dumea, Elena, et al.
Publicado: (2014)

Hepatitis B Virus Infection in HIV-Positive Individuals in the UK Collaborative HIV Cohort (UK CHIC) Study
por: Price, Huw, et al.
Publicado: (2012)

Simple Does Not Mean Trivial: Behavior of Phosphatidic Acid in Lipid Mono- and Bilayers
por: Drabik, Dominik, et al.
Publicado: (2021)

Association between Noninvasive Fibrosis Markers and Cardio-Vascular Organ Damage among Adults with Hepatic Steatosis
por: Sesti, Giorgio, et al.
Publicado: (2014)

Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
por: Song, Do Seon, et al.
Publicado: (2019)

Acute mono-megakaryoblastic leukemia associated with extreme thrombocytosis and complex karyotype abnormalities
por: Hu, Rong, et al.
Publicado: (2013)

Cost‐effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation
por: Crossan, C., et al.
Publicado: (2015)

A viewpoint: The 2022 monkeypox outbreak
por: Simões, Pedro, et al.
Publicado: (2022)

Non-catheter simple noninvasive bladder draining method with no costs
por: Hocking, M. G.
Publicado: (2010)

Evaluation of hepatic fibrosis with noninvasive methods: transient elastography in HIV infected patients
por: Dumea, Elena, et al.
Publicado: (2013)

Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis
por: Colomba, Johann, et al.
Publicado: (2019)

Association between Noninvasive Fibrosis Markers and Chronic Kidney Disease among Adults with Nonalcoholic Fatty Liver Disease
por: Sesti, Giorgio, et al.
Publicado: (2014)

Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens
por: Busca, C, et al.
Publicado: (2022)

Serum Gamma-Glutamyl Transpeptidase-to-Platelet Ratio as a Noninvasive Marker of Liver Fibrosis in Chronic Hepatitis B
por: Purkayastha, Subham, et al.
Publicado: (2023)

Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
por: Goyale, Atul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k4dqlhheb1ulomlcv8qvcmeo7u